Mohammed M Alruwaili

7PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 13, 2026
Development and Optimization of Sodium Deoxycholate-Stabilised Shellac-Based Polymeric Nanoparticles for Enhanced Pharmacokinetics and Anticancer Activity of Etodolac in Hepatocellular Carcinoma.

|Aug 13, 2026
Neoadjuvant PD-1-Based Immunotherapy in Localized dMMR/MSI-H Colorectal Cancer: A Systematic Review and Arm-Based Meta-Analysis.

|Apr 03, 2026
Exploring the role of PARP9 expression in AML: prognostic implications and transcriptomic insights.

Abdullah Alshammari, Abdulrahman Algarni, Priyanka Guru

|Nov 24, 2025
A Sequential Triple-Drug Strategy for Selective Targeting of p53-Mutant Cancers.

Mohammed M Alruwaili, Yanqi Guo, Justin Zonneville

|Sep 15, 2025
BOGO: A Proteome-Wide Gene Overexpression Platform for Discovering Rational Cancer Combination Therapies.

Kyeong Beom Jo, Mohammed M Alruwaili, Da-Eun Kim

|Jul 14, 2025
p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancer.

Priyanka Rajan, Robert Zollo, Yanqi Guo

Pageof 2

Frequent Collaborators

4 joint publications

Andrei V Bakin

3 joint publications

Justin Zonneville

2 joint publications

Priyanka Rajan

2 joint publications

Yanqi Guo